What is NIPT
November 14, 2025
What Is an Oncology Test?
November 14, 2025What is NIPT
November 14, 2025What Is an Oncology Test?
November 14, 2025
Carrier Screening Test
Carrier Screening Test analyzes the DNA from a blood sample taken from either parent to identify genetic disease risks that may pass to the unborn baby. It is recommended for couples planning a pregnancy and enables early awareness of possible genetic risks.
Carrier Screening Test
A powerful approach to understanding family risks. Carrier screening is a modern genetic analysis method used to identify genetic disease risks that can be passed to a baby even when neither parent shows symptoms. It helps families learn about potential risks early during pregnancy planning.
Comprehensive evaluation from a simple blood sample. The test is performed by analyzing DNA from a blood sample taken from either parent. Carrier statuses for genetic conditions are detected, helping couples make more informed decisions for future pregnancies.
Wide-ranging analysis of genetic conditions. Carrier screening can detect carrier status for many hereditary diseases, clearly revealing potential risks both before and during early pregnancy.
Early information for a healthy pregnancy.
The carrier screening test allows families to learn their genetic risks in advance, helping prevent potential diseases. The process is completely safe, fast, and supported by specialist evaluation.
For Your Future Generations TATA Carrier Screening Test
Scientifically evaluate your genetic risks for common hereditary diseases through carrier screening, before or during pregnancy planning.
- Mini Panel Includes carrier screening for SMA (MLPA) and Cystic Fibrosis (sequence analysis).
- MiniX Panel In addition to SMA and Cystic Fibrosis, it screens for Fragile X and DMD carrier status. Particularly recommended for expectant mothers.
- Maxi Panel Using next-generation sequencing (NGS), more than 260 genes are analyzed to screen for autosomal recessive and X-linked diseases.
- Maxi Panel + SMA In addition to the Maxi Panel, Spinal Muscular Atrophy (SMA) carrier status is also detected via MLPA.
Who Is the TATA Carrier Screening Test Recommended For?
TATA is recommended in the following situations where early detection of carrier disease risk is important:
Who Should Get Tested?
- Couples planning a pregnancy,
- Individuals with a family history of genetic disease,
- Couples who have experienced previously unexplained pregnancy loss,
- Couples with consanguineous marriage,
- Families wishing to learn about the risk of genetic disease in the unborn baby,
- Healthy individuals wondering whether they are carriers,
- Couples wishing to assess risks in advance for future pregnancies.
How Is the Carrier Screening Test Performed?
- Initial consultation: Family history and needs are evaluated.
- Bilgilendirme & onam: The test process is explained and consent obtained.
- Sample collection: A routine blood sample is taken from either parent.
- DNA analizi: DNA is isolated and analyzed from the blood sample.
- Genetik tarama: Comprehensive analysis is performed to identify possible carrier statuses.
- Evaluation of findings: Results are interpreted by a specialist genetics team.
- Counseling: Risks and possible options are explained to the family in detail.
